Endocrine Society Annual Meeting

Articles

An assessment of the world's largest twin registry found telling patterns of common autoimmune diseases including type 1 diabetes.

Cluster, Genetic Trends Observed in Autoimmune Diseases

No significant differences in cardiovascular outcomes among patients receiving different GLP-1 agonists including exenatide extended-release, exenatide immediate-release, liraglutide, albiglutide, and dulaglutide.

Study Examines Cardiovascular Effects of GLP-1 Agonists

Over the course of 16 weeks, OSA patients receiving CPAP treatment lost 5.7 pounds more on average than patients not receving CPAP therapy.

CPAP May Aid in Patient Weight Loss

A year-long outpatient care study showed that patients with type 2 diabetes and comorbid cardiovascular disease are 5 times as likely to visit a cardiologist.

Cardiologists Far More Likely to See Diabetic Patient than Endocrinologists

A new Puerto Rico-based trial shows that patients on add-on SGLT-2 inhibitors reported greater HbA1C reductions.

Hispanic Patients with T2DM Benefit from Adjunct SGLT-2 Therapy

Decreases in anabolic hormone levels, vitamin D linked to weakening with age.

Study Shows â€œNovel Associationsâ€ Between Anabolic Hormone Levels and Frailty in Old Age

Videos

Could insulin could be dosed off of values from a continuous glucose monitor? Anne Peters, MD, and team sought to find out.

REPLACE-BG Trial: Making Safe Insulin Dosing Decisions Based on CGM Data

A project from the University of New Mexico looks to turn physicians to experts.

Using Telehealth to Spread Expertise for the Treatment of Rural Diabetes

 Bradley Miller, MD, University of Minnesota Academic Health Center hopes the team learns â€œgood informationâ€ about how kids are growing on this dose of somavaratan that will then be confirmed in the phase 3 head-to-head with growth hormone daily.
 